ROMA VASWANI: Open Payments
NPI 1649812272 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$275 in 16 payments from 4 companies in 2025. Trend: 2023 $268 · 2024 $259 · 2025 $275
Food & beverage: $275
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $187 |
| Boston Scientific Corporation | 1 | $43 |
| Gilead Sciences, Inc. | 1 | $23 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
Products named: Ozempic, Wegovy, APOLLO ESG System, GEMTESA.
Industry payments across TX — which companies pay providers there.
